Author: Dzmitry Korsak

Avatar photo

Experienced journalist and editor with over 25 years in the field. His work focuses on medical technologies, social issues, and innovation. He values an evidence-based approach, thorough work with primary sources, and the ability to communicate complex topics in a clear and accessible way.

Japan’s Dai Nippon Printing has unexpectedly set its sights on a market where until now one name has reigned supreme — ASML. The Dutch company controls around 90% of the global lithography equipment market and effectively holds a monopoly on EUV scanners, without which the most advanced chips are impossible. All modern electronics — from AI data centers to smartphones — quite literally depend on a single company and its machines.

As recently as yesterday, 32 GB of RAM for a PC was a routine purchase; today it looks like a full-fledged investment appreciating faster than gold and certainly faster than bitcoin. What is increasingly resembles a brewing crisis: the race to ramp up AI capacity is often coming at the expense of other sectors, and manufacturers whose products have had the good fortune to become coveted in this race are quick to reshuffle priorities, with little concern for the consequences for ordinary users.

American shoppers once again staged a record shopping marathon: according to Adobe Analytics, they spent $11.8 billion online on Black Friday 2025, 9.1% more than a year earlier. Globally, analysts put total online Black Friday sales at around $78–80 billion — and a substantial share of that pie now comes from European consumers hunting for discounts and increasingly turning to AI to help them choose what to buy.

We trust fitness trackers to count our steps and calories, but can we trust a smartphone or watch with our sleep? It turns out, yes, provided we are talking about apps that have undergone clinical trials and received medical approval. Let’s look at three digital solutions that go beyond collecting data to actually diagnosing and treating sleep disorders.

Femtech is booming. According to FemTech Analytics, the sector is on track https://www.femtech.health/interactive-charts to reach $75.1 billion by 2025. Yet there’s also a “silent” potential worth $360 billion — an invisible market still untouched by today’s industry. Flo has long been a femtech synonym, but once you set aside that “obligatory first line,” you’ll find plenty of robust, evidence-based, and, crucially, battle-tested alternatives. Here are three apps we think deserve your attention.

The gaming industry ceased to be something unserious or just for children long ago. It is a huge market with pharma-level budgets, top-tier development teams, advanced R&D units, and extremely fine-tuned work with human attention, motivation, and behavior. It is only logical that medicine is looking more and more in this direction – if games can keep people engaged for hours, why not use the same mechanics when a patient needs help getting through treatment, rehabilitation, or complex learning?

As the year draws to a close, major analytics firms traditionally share their view on where the medtech industry is heading and what to expect in the near future. We have gone through these reports and distilled the essentials: from the explosive growth of AI in medical devices and the portable tech market to regional regulatory specifics and shifting investment priorities. This article brings together the key figures, insights, and directions that will shape medtech over the coming years.